ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

dexketoprofen

Also written as “Dexketoprofen Trometamol + Tramadol Hydrochloride”, “Dexketoprofen/Tramadol-single dose” and “Dexketoprofen/Tramadol-multiple doses”.

Its studies are mostly in Acute Pain · Dysmenorrhea · Low Back Pain · Venous Thrombosis · Pain, led by 2 companies.

Drug pageDexketoprofen: every studyAll 47 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since May 13, 20168 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Menarini Group60 open or runningphase 4since May 13, 2016Feb 28, 2011none ahead
Laboratorios Silanes S.A. de C.V.its history only20 open or runningphase 3since Jul 29, 2021Jul 29, 2021none ahead

Also a collaborator on its studies: Simbec Research and PRA Health Sciences.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Menarini Group only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Feb 28, 2011First study: phase 2 study in PainFirst studyNCT01307020 · 745 enrolled · Germany, Hungary, Italy and more
  2. Jun 14, 2013Phase 3 study in Venous ThrombosisNCT01880216 · 312 enrolled · Georgia, Russian Federation
  3. Jul 15, 20132 phase 3 studies in Acute PainNCT01902134, NCT01904149
  4. Aug 4, 2014Phase 1 study in Acute PainNCT02209454 · 26 enrolled · United Kingdom
  5. May 13, 2016Phase 4 study in Acute PainNCT02777970 · 654 enrolled · Hungary, Italy, Poland and more

TargetBeta

PTGS1 →PTGS2 →read by rule
“Cyclooxygenase inhibitor”ChEMBL 37, by rule

Other programs on the same two targets

ProgramCompanyFurthest phaseStudies
AcetaminophenruleJohnson & Johnsonphase 4136
IbuprofenrulePfizerphase 4113
AspirinruleBayerphase 484
SulfasalazineruleBristol-Myers Squibbphase 47
dexibuprofenruleaponia-laboratories-incphase 46
BenzydamineruleAngelini Pharmaphase 44
DipyroneruleHypera Pharmaphase 44
PiroxicamruleTaisho Pharmaceuticalphase 44
FlurbiprofenruleGlaxoSmithKlinephase 312

Studies

All 6 Menarini Group leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02777970Acute Pain · Hungary, Italy, Poland and more4CompletedFeb 14, 2017654
NCT02209454Acute Pain · United Kingdom1CompletedMay 201426
NCT01904149Acute Pain · Hungary, Latvia, Lithuania and more3CompletedMay 2014606
NCT01902134Acute Pain · Czech Republic, Germany, Hungary and more3CompletedFeb 2014641
NCT01880216Venous Thrombosis · Georgia, Russian Federation3CompletedJan 2015312
NCT01307020Pain · Germany, Hungary, Italy and more2CompletedOct 2011745

How it is read

Names in the registry

  • “Dexketoprofen Trometamol + Tramadol Hydrochloride”, 4 entries
  • “Dexketoprofen/Tramadol-single dose”, 2 entries
  • “Dexketoprofen/Tramadol-multiple doses”, 2 entries
  • “Dexketoprofen / Butylscopolamine in fixed dose combination tablet. (Laboratorios Silanes S.A. de C.V.)”, 1 entry
  • “Dexketoprofen/Vitamin B”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.